Dexamethasone isn’t a coronavirus breakthrough
From our UK edition
It’s welcome news, of course, that dexamethasone can reduce mortality in people with moderate to severe respiratory complications due to Covid-19. But to hail it as a big breakthrough – as the Health Secretary Matt Hancock did this week – is a step too far. Perhaps next week, Hancock will be shouting about the use of paracetamol as a treatment for headaches. Dexamethasone has been around for decades – which explains why it is relatively cheap and there is lots of it – and is already used widely for those suffering from respiratory distress. In other words, it is pretty much a standard treatment for those afflicted with symptoms similar to those caused by Covid-19.